Clinical Trial Update: A Safety, Tolerability and Preliminary Efficacy Study of BBI-4000 Gel in Subjects With Palmar Hyperhidrosis [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety, tolerability, and preliminary efficacy of BBI-4000 Gel in palmar hyperhidrosis completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperhidrosis
• Palmar Hyperhidrosis

Drugs mentioned

• BBI-4000 Gel

Snippet

Sponsor: Botanix Pharmaceuticals | Conditions: Hyperhidrosis | Phase 2 | Status: COMPLETED | Results posted: 2023-05-19